Edgestream Partners, L.P. Abbott Laboratories Transaction History
Edgestream Partners, L.P.
- $2.29 Billion
- Q4 2024
A detailed history of Edgestream Partners, L.P. transactions in Abbott Laboratories stock. As of the latest transaction made, Edgestream Partners, L.P. holds 3,492 shares of ABT stock, worth $450,712. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,492
Previous 16,293
78.57%
Holding current value
$450,712
Previous $1.86 Million
78.78%
% of portfolio
0.02%
Previous 0.08%
Shares
23 transactions
Others Institutions Holding ABT
# of Institutions
3,247Shares Held
1.31BCall Options Held
8.71MPut Options Held
8.02M-
Vanguard Group Inc Valley Forge, PA168MShares$21.7 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$16.9 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$9.9 Billion0.36% of portfolio
-
Capital International Investors Los Angeles, CA65.7MShares$8.49 Billion1.49% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.88 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $226B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...